Because the objective of a clinical trial is to provide reliable evidence of the efficacy and safety of a treatment, a major issue in the design of clinical trials is ensuring we have a sufficient number of patients to provide the required level of evidence. Essentially, we need to have enough subjects in our trial to give a good chance of detecting a clinically important treatment difference if such a difference exists, while being able to reasonably conclude that no such difference exists if our results do not show it. The focus of this article is the sample size calculation for superiority trials. There are different methods in determining the sample size in trials with a non-inferiority design, or those that are randomized by cluster rather than individually. In order to appreciate the basics of sample size requirements for a trial, some understanding of key statistical concepts is essential.
Evangelista, MT & Huber, N. (2017). Sample size calculation 101: unraveling the concepts behind the numbers. Journal of the Philippine Dermatological Society, 26(2), 18-21.
clinical trial, sample size, calculation
Syringocystadenoma papilliferum arising from a nevus sebaceus mimicking squamous cell carcinoma in a Filipino female: A case report
Authors: Maria Kristina R. Fajardo, MD, Daisy King-Ismael, MD, FPDS,Bernardita O. Policarpio, MD, FPDSAbstract INTRODUCTION :Syringocystadenoma papilliferum (SCAP) is a relatively rare benign adnexal skin tumor which can manifest in a variety of clinical forms. Nearly...
Drug-induced chronic bullous disease of childhood in a two-year-old Filipino male triggered by cefaclor or cefuroxime: A case report
Authors: Sher Claranza O. Liquido, MD, Maria Jasmin J. Jamora, MD, FPDSAbstract Introduction: N Chronic bullous disease of childhood (CBDC) is a rare immune-mediated subepidermal vesiculobullous eruption, characterized by linear IgA deposition along the basement...
Authors: Ma. Corazon A. Iniego-Rodas, MD, DPDS, Maria Franchesca Quinio, MD, FPDS, DDSP-PDS, Charlene Ang-Tiu, MD, FPDSAbstract INTRODUCTION : Lupus panniculitis (LP) is an unusual type of cutaneous lupus erythematosus (CLE) wherein the cutaneous inflammatory reaction...